Clotting factor concentrates (CFC) or bypassing agents (BPA) Clinical Trials
2 recruitingBiologic
Phase 31Phase 41
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Hemophilia
Sanofi85 enrolled21 locationsNCT07285460
Recruiting
Phase 4
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Hemophilia A
Sanofi20 enrolled2 locationsNCT06145373